Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Werewolf Therapeutics, Inc. | 5,125,770 | reported | 25 Nov 2025 | tx 3−195,666 |
| Harpoon Therapeutics, Inc. | 4,274,425 | reported | 12 Feb 2019 | tx 15+4,203,886−3,955,410 |
| iTeos Therapeutics, Inc. | 0 | reported | 28 Jul 2020 | tx 30+3,706,663−11,003,934 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 25 Nov 2025 | SALE | Werewolf Therapeutics, Inc. | 42,533 | 0.92 USD | |
| 21 Nov 2025 | SALE | Werewolf Therapeutics, Inc. | 64,331 | 0.83 USD | |
| 24 Nov 2025 | SALE | Werewolf Therapeutics, Inc. | 88,802 | 0.98 USD | |
| 28 Jul 2020 | PURCHASE | iTeos Therapeutics, Inc. | 1,121 | 19.00 USD | |
| 28 Jul 2020 | PURCHASE | iTeos Therapeutics, Inc. | 3,020 | 19.00 USD | |
| 28 Jul 2020 | PURCHASE | iTeos Therapeutics, Inc. | 56,814 | 19.00 USD | |
| 28 Jul 2020 | PURCHASE | iTeos Therapeutics, Inc. | 3,096 | 19.00 USD | |
| 28 Jul 2020 | PURCHASE | iTeos Therapeutics, Inc. | 5,994 | 19.00 USD | |
| 28 Jul 2020 | PURCHASE | iTeos Therapeutics, Inc. | 89,955 | 19.00 USD | first after silence |
| 28 Jul 2020 | CONVERSION | iTeos Therapeutics, Inc. | 9,033 | — | |
| 28 Jul 2020 | CONVERSION | iTeos Therapeutics, Inc. | 24,326 | — | |
| 28 Jul 2020 | CONVERSION | iTeos Therapeutics, Inc. | 457,706 | — | |
| 28 Jul 2020 | CONVERSION | iTeos Therapeutics, Inc. | 24,944 | — | |
| 28 Jul 2020 | CONVERSION | iTeos Therapeutics, Inc. | 48,336 | — | |
| 28 Jul 2020 | CONVERSION | iTeos Therapeutics, Inc. | 15,820 | — | |
| 28 Jul 2020 | CONVERSION | iTeos Therapeutics, Inc. | 42,605 | — | |
| 28 Jul 2020 | CONVERSION | iTeos Therapeutics, Inc. | 801,619 | — | |
| 28 Jul 2020 | CONVERSION | iTeos Therapeutics, Inc. | 43,687 | — | |
| 28 Jul 2020 | CONVERSION | iTeos Therapeutics, Inc. | 84,655 | — | |
| 28 Jul 2020 | CONVERSION | iTeos Therapeutics, Inc. | 1,269,230 | — | |
| 28 Jul 2020 | CONVERSION | iTeos Therapeutics, Inc. | 724,702 | — | |
| 28 Jul 2020 | CONVERSION | iTeos Therapeutics, Inc. | 2,361,805 | — | deriv |
| 28 Jul 2020 | CONVERSION | iTeos Therapeutics, Inc. | 157,529 | — | deriv |
| 28 Jul 2020 | CONVERSION | iTeos Therapeutics, Inc. | 81,295 | — | deriv |
| 28 Jul 2020 | CONVERSION | iTeos Therapeutics, Inc. | 1,491,666 | — | deriv |
1 purchase reported after at least 12 months of silence — most recent on 28 Jul 2020.